FDA Investigator Rapti D Madurawe
Rapti D Madurawe has inspections in 1 countries as of 19 Apr 2023. Rapti D Madurawe has collaborated with a combined 865 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
2
Last Inspection Date:
19 Apr 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Anthony C Warchut,
Ariel Cruz Figueroa,
Arlene M Badillo,
Byungja E Marciante,
Christine M Smith,
Christopher Janik,
Chunsheng Cai, PhD,
Darin S Wiegers,
Diane C Thibodeau,
Dien N Nguyen,
Edmund F Mrak, Jr,
Edward J Janik,
Edwin Martinez,
Gabrielle J Swain,
German Rivera,
Hang N Guo,
Jonah S Ufferfilge,
Jorge L Guadalupe,
Jose Alopez Rubet,
Jose E Melendez, DDC,
Kent A Conforti,
Krishna Ghosh, PhD,
Lareese K Thomas,
Laurimer Kuilan Torres,
Libia M Lugo,
M Patriciaurphy Murphy,
Margaret M Sands,
Marian E Ramirez,
Marianela Aponte Cruz,
Mark R Mcclain,
Matthew C Watson,
Maya M Davis,
Michelle M Noe,
Myriam M Sosa,
Nealie C Newberger,
Nina Yang,
Noreen Muniz,
Peter R Lenahan,
Ramon A Hernandez,
Raquel Gonzalez,
Raquel Gonzalez Rivera,
Rebecca Parrilla,
Stephanie Mangigian, MS/OSH, RN,
Stephen R Souza,
Victoria M Daddeo,
Vilmary Negron Rodriguez,
Ying Zhang
Rapti D Madurawe's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2017 | FDA 483 | Lilly del Caribe, Inc. - Form 483, 2017-07-21 |
July, 2018 | EIR | Pfizer Laboratories Div Pfizer Inc - EIR, 2018-07-18 |
July, 2018 | FDA 483 | Pfizer Laboratories Div Pfizer Inc - Form 483, 2018-07-18 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more